Mankind Pharma Limited (MANKIND.BO)
INR 2846.55
(1.46%)
INR 2846.55
(1.46%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 103.34 Billion | 87.42 Billion | 77.81 Billion | 62.14 Billion | 58.65 Billion | 49.79 Billion |
| Cost of Revenue | 58.82 Billion | 53.54 Billion | 24.7 Billion | 18.24 Billion | 19.23 Billion | 17.51 Billion |
| Gross Profit | 44.52 Billion | 33.88 Billion | 53.11 Billion | 43.89 Billion | 39.41 Billion | 32.28 Billion |
| Operating Expenses | 23.15 Billion | 17.7 Billion | 34.33 Billion | 27.82 Billion | 24.73 Billion | 23.19 Billion |
| Selling, General and Administrative Expenses | 9.89 Billion | 14.68 Billion | 6.58 Billion | 5.22 Billion | 3.55 Billion | 14.7 Billion |
| Research and Development Expenses | - | 1.88 Billion | 2.13 Billion | 1.7 Billion | - | 1.1 Billion |
| Other Expenses | - | -1.13 Billion | 130.01 Million | 100.2 Million | 97.27 Million | - |
| Cost and Expenses | 81.97 Billion | 71.24 Billion | 59.03 Billion | 46.07 Billion | 43.96 Billion | 40.7 Billion |
| Operating Income | 21.51 Billion | 16.17 Billion | 19.23 Billion | 16.65 Billion | 15.13 Billion | 8.69 Billion |
| Interest Expense | 285.99 Million | 444.69 Million | 557.8 Million | 193.03 Million | 219.23 Million | - |
| Income Tax Expense | 4.57 Billion | 3.61 Billion | 5.21 Billion | 3.98 Billion | 3.81 Billion | 2.64 Billion |
| Earnings before Tax | 23.84 Billion | 16.58 Billion | 19.74 Billion | 16.91 Billion | 14.37 Billion | 8.74 Billion |
| Net Income | 19.12 Billion | 12.81 Billion | 14.33 Billion | 12.65 Billion | 10.3 Billion | 5.78 Billion |
| Earnings Per Share Basic | 47.75 | 32.00 | 35.78 | 31.59 | 25.72 | 14.44 |
| Earnings Per Share Diluted | 47.68 | 32.00 | 35.78 | 31.59 | 25.72 | 14.44 |
| Weighted Average Shares Outstanding | 400.6 Million | 400.58 Million | 400.58 Million | 400.58 Million | 400.58 Million | 400.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 401.16 Million | 400.59 Million | 400.58 Million | 400.58 Million | 400.58 Million | 400.58 Million |
| Gross Margin | 0.43 | 0.39 | 0.68 | 0.71 | 0.67 | 0.65 |
| EBIT Margin | 0.27 | 0.22 | 0.27 | 0.29 | 0.27 | 0.19 |
| Profit Margin | 0.19 | 0.15 | 0.18 | 0.20 | 0.18 | 0.12 |
| EBITDA | 28.09 Billion | 20.26 Billion | 21.46 Billion | 18.16 Billion | 15.4 Billion | 9.35 Billion |
| Earnings Before Tax Margin | 0.21 | 0.19 | 0.25 | 0.27 | 0.26 | 0.17 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 28.93 Billion | 24.41 Billion | 103.34 Billion | 26.06 Billion | 27.08 Billion | 25.78 Billion |
| Cost of Revenue | 15.54 Billion | 14.23 Billion | 58.82 Billion | 8.27 Billion | 8.24 Billion | 8.19 Billion |
| Gross Profit | 13.39 Billion | 10.17 Billion | 44.52 Billion | 17.79 Billion | 18.83 Billion | 17.58 Billion |
| Operating Expenses | 7.65 Billion | 5.31 Billion | 23.15 Billion | 12.82 Billion | 12.97 Billion | 11.91 Billion |
| Selling, General and Administrative Expenses | 7.65 Billion | 5.31 Billion | - | 6.04 Billion | 6.28 Billion | 5.5 Billion |
| Research and Development Expenses | - | 254.53 Million | - | - | - | - |
| Other Expenses | 1 Billion | 921.28 Million | 2.8 Billion | 701.32 Million | 599.78 Million | 586.18 Million |
| Cost and Expenses | 23.19 Billion | 19.54 Billion | 81.97 Billion | 21.1 Billion | 21.21 Billion | 20.11 Billion |
| Operating Income | 5.74 Billion | 4.86 Billion | 21.36 Billion | 5.71 Billion | 6.49 Billion | 6.3 Billion |
| Interest Expense | 109.1 Million | 93.82 Million | 335.31 Million | 91.85 Million | 86.24 Million | 63.39 Million |
| Income Tax Expense | 1.24 Billion | 949.83 Million | 4.57 Billion | 1.02 Billion | 1.29 Billion | 1.3 Billion |
| Earnings before Tax | 6.63 Billion | 5.69 Billion | 23.84 Billion | 5.62 Billion | 6.4 Billion | 6.24 Billion |
| Net Income | 5.36 Billion | 4.71 Billion | 19.12 Billion | 4.53 Billion | 5.01 Billion | 4.86 Billion |
| Earnings Per Share Basic | 13.39 | 11.76 | - | 11.33 | 12.51 | 12.15 |
| Earnings Per Share Diluted | 13.37 | 11.74 | - | 11.31 | 12.49 | 12.14 |
| Weighted Average Shares Outstanding | 400.63 Million | 400.6 Million | 400.6 Million | 400.58 Million | 400.58 Million | 400.58 Million |
| Weighted Average Shares Outstanding (Diluted) | 401.26 Million | 401.19 Million | 401.19 Million | 401.2 Million | 401.14 Million | 400.58 Million |
| Gross Margin | 0.46 | 0.42 | 0.43 | 0.68 | 0.70 | 0.68 |
| EBIT Margin | 0.24 | 0.24 | - | 0.26 | 0.28 | 0.28 |
| Profit Margin | 0.19 | 0.19 | 0.19 | 0.17 | 0.19 | 0.19 |
| EBITDA | 6.81 Billion | 5.91 Billion | - | 6.81 Billion | 7.46 Billion | 7.18 Billion |
| Earnings Before Tax Margin | 0.20 | 0.20 | 0.21 | 0.22 | 0.24 | 0.24 |
RCC
KHNGF
IMCC
VICA
OXY-WT
ACNNF